BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/15/2015 5:36:00 PM | Browse: 995 | Download: 1292
Publication Name World Journal of Translational Medicine
Manuscript ID 20824
Country Japan
Received
2015-06-24 10:28
Peer-Review Started
2015-06-29 12:18
To Make the First Decision
2015-07-28 10:50
Return for Revision
2015-08-10 09:56
Revised
2015-08-28 09:39
Second Decision
2015-09-29 17:21
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2015-10-13 18:06
Articles in Press
2015-10-13 18:06
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2015-12-11 09:51
Publish the Manuscript Online
2015-12-15 17:37
ISSN 2220-6132 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Research & Experimental Medicine
Manuscript Type Basic Study
Article Title New categorization of human vascular endothelial cells by pro- vs anti-proliferative phenotypes
Manuscript Source Invited Manuscript
All Author List Miwako Nishio, Masako Nakahara, Chikako Sato, Koichi Saeki, Hidenori Akutsu, Akihiro Umezawa, Kazuyuki Tobe, Kazuki Yasuda, Akira Yuo and Kumiko Saeki
Funding Agency and Grant Number
Funding Agency Grant Number
Ministry of Health, Labour and Welfare of Japan KHD1017
JST and PRESTO
Corresponding Author Kumiko Saeki, MD, PhD, Division Chief, Department of Disease Control, Research Institute, National Center for Global Health and Medicine, 1-21-1 Toyama Shinjuku-ku, Tokyo 162-8655, Japan. saeki@ri.ncgm.go.jp
Key Words Vascular endothelial cells; Vascular smooth muscle cells; Human induced pluripotent stem cells; Human embryonic stem cells; Regulator of G-protein signaling 5; Oxidative stress
Core Tip There is a longstanding controversy over the effects of vascular endothelial cells (VECs) on the proliferation of vascular smooth muscle cells (VSMCs). Since the controversy came from lack of systematic studies, we performed an integrated analysis using various human VECs to quantitatively evaluate their effects on VSMC proliferation. Here we report that: (1) human VECs are classified into two groups: “pro-proliferative (type-I) vs “anti-proliferative” (type-II); (2) oxidative stress and ageing induced “type-II to type-I” conversion; and (3) RGS5 is the responsible gene for VEC phenotype determinations. Thus, human VECs are categorized into pro-proliferative RGS5high (type-I) and anti-proliferative RGS5low (type-II) VECs.
Publish Date 2015-12-15 17:37
Citation Nishio M, Nakahara M, Sato C, Saeki K, Akutsu H, Umezawa A, Tobe K, Yasuda K, Yuo A, Saeki K. New categorization of human vascular endothelial cells by pro- vs anti-proliferative phenotypes. World J Transl Med 2015; 4(3): 88-100
URL http://www.wjgnet.com/2220-6132/full/v4/i3/88.htm
DOI http://dx.doi.org/10.5528/wjtm.v4.i3.88
Full Article (PDF) WJTM-4-88.pdf
Full Article (Word) WJTM-4-88.doc
Manuscript File 20824-Review.docx
Answering Reviewers 20824-Answering reviewers.pdf
Audio Core Tip 20824-Audio core tip.wma
Clinical Trial Registration Statement 20824-Clinical trial registration statement.pdf
Conflict-of-Interest Disclosure Form 20824-Conflict-of-interest statement.pdf
Copyright License Agreement 20824-Copyright assignment.pdf
Signed Informed Consent Form(s) or Document(s) 20824-Clinical trial registration statement.pdf
Institutional Review Board Approval Form or Document 20824-Institutional review board statement.pdf
Non-Native Speakers of English Editing Certificate 20824-Language certificate.pdf
Peer-review Report 20824-Peer-review(s).pdf
Scientific Misconduct Check 20824-Scientific misconduct check.pdf
Scientific Editor Work List 20824-Scientific editor work list.pdf